Background: Iodine deficiency produces the spectrum of iodine deficiency disorders (IDDs): endemic goiter, hypothyroidism, cretinism, and congenital anomalies. Other factors, including goitrogens and micronutrient deficiencies, may influence the prevalence and severity of IDDs and response to iodine supplementation. This cross-sectional, descriptive study was performed in 2003 on elementary school children of Semirom, a mountainous region of Iran, where goiter was hyper-endemic in 1994, but the goiter prevalence had not decreased as expected many years after salt iodization and iodine injection. Some possible risk factors associated with goiter in that area were evaluated, and the results of iron study are presented here. Methods: 1,869 cases were selected by a multistage cluster sampling procedure. Grade 2 goitrous children were compared with equal number of nongoitrous children for serum iron, ferritin, transferrin, thyroxin, TSH and urine iodine concentrations (UIC). Results: 210 children (105 goiter grade 0 and 105 goiter grade 2) entered this sub-study. Of 210 participants, 70 children had low transferrin saturation, 13 had low serum ferritin and 9 children had both problems. There was no significant difference in goiter rate between children with low iron indices and others.There was no significant correlation between serum iron, ferritin or transferrin saturation with other variables including T4, UIC and goiter stage. Conclusion: The present study reveals that in the area studied, iron deficiency cannot explain the high prevalence of goiter, so other responsible factors should be investigated.

Keywords:
Goiter, Iodine deficiency, Iron deficiency, Salt iodization, Transferrin, Ferritin
1.
World Health Organization, United Nations Children’s Fund and International Council for the Control of Iodine Deficiency Disorders: Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination, WHO/NHD/01.1. Geneva, WHO, 2001.
2.
WHO, UNICEF and ICCIDD: Indicators for Assessing Iodine Deficiency Disorders and Their Control through Salt Iodinization. WHO/NUT.94.6. Geneva, WHO, 1994.
3.
Bailey KV, Clugston GA: Iodine deficiency disorders; in Murray CJL, Lopez AD (eds): The Global Burden of Disease and Risk Factors in 1990, Geneva, WHO/World Bank, 1990, pp 36–40.
4.
Boyages SC: Clinical review 49: iodine deficiency disorders. J Clin Endocrinol Metab 1993;77:587–591.
5.
Furnee CA: Prevention and control of iodine deficiency: a review of a study on the effectiveness of oral iodized oil in Malawi. Eur J Clin Nutr 1997;51(suppl 4):S9–S10.
6.
Thilly CH, Vanderpas JB, Bebe N, Ntambue K, Contempre B, Swennen B, Moreno-Reyes R, Bourdoux P, Delange F: Iodine deficiency, other trace elements and goitrogenic factors in the etiopathology of iodine deficiency disorders. Biol Trace Element Res 1992;32:229–243.
7.
Zimmermann MB, Adou P, Torresani T, Zeder C, Hurrell RF: Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. Eur J Clin Nutr 2000;54:209–213.
8.
Hess SY, Zimmermann MB: The effect of micronutrient deficiencies on iodine nutrition and thyroid metabolism. Int J Vitam Nutr Res 2004;74:103–115.
9.
Hurrell RF: Bioavailability of iodine. Eur J Clin Nutr 1997;51(suppl 1):S9–S12.
10.
Karamifar H, Shahriari M, Sadjadian N: Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran. East Mediterr Health J 2003;9:55–60.
11.
Tienboon P, Unachak K: Iron deficiency anaemia in childhood and thyroid function. Asia Pac J Clin Nutr 2003;12:198–202.
12.
Zimmermann M, Adou P, Torresani T, Zeder C, Hurrell R: Persistence of goiter despite oral iodine supplementation in goitrous children with iron deficiency anemia in Cote d’Ivoire. Am J Clin Nutr 2000;71:88–93.
13.
ACC/SCN: Second Report on the World Nutrition Situation, vol 1. Global and regional results. ACC/SCN: Geneva, 1992.16 Ministry of Health. Plan National d’Action pour la Nutrition. Côte d’Ivoire, Ministry of Health, 1994.
14.
Zimmermann M, Adou P, Torresani T, Zeder C, Hurrell R: Iron supplementation in goitrous, iron-deficient children improves their response to oral iodized oil. Eur J Endocrinol 2000;142:217–223.
15.
Beard JL, Borel MJ, Derr J: Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am J Clin Nutr 1990;52:813–819.
16.
Beard JL, Brigham DE, Kelley SK, Green MH: Plasma thyroid hormone kinetics are altered in iron-deficient rats. J Nutr 1998;128:1401–1408.
17.
Dillman E, Gale C, Green W, Johnson DG, Mackler B, Finch C: Hypothermia in iron deficiency due to altered triiodothyronine metabolism. Am J Physiol 1980;239:R377–R381.
18.
Ackrell BA, Maguire JJ, Dallman PR, Kearney EB: Effect of iron deficiency on succinate- and NADH-ubiquinone oxidoreductases in skeletal muscle mitochondria. J Biol Chem 1984;259:10053–10059.
19.
Smith SM: Indices of in vivo and in vitro thyroid hormone metabolism in iron-deficient rats. Nutr Res 1994;14:729–739.
20.
Hess SY, Zimmermann MB, Adou P, Torresani T, Hurrell RF: Treatment of iron deficiency in goitrous children improves the efficacy of iodized salt in Cote d’Ivoire. Am J Clin Nutr 2002;75:743–748.
21.
Azizi F, Mehran L: Experiences in the prevention, control and elimination of iodine deficiency disorders: a regional perspective. East Mediterr Health J 2004;10:761–770.
22.
Pino S, Fang SL, Braverman LE: Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clin Chem 1996;42:239–243.
23.
Aghini-Lombardi F, Antonangeli L, Pinchera A, Leoli F, Rago T, Bartolomei AM, et al: Effect of iodized salt on thyroid volume of children living in an area previously characterized by moderate iodine deficiency. J Clin Endocrinol Metab 1997;82:1136–1139.
24.
Delange F, De Benoist B, Pretell E, Dunn JT: Iodine deficiency in the world: where do we stand at the turn of the century? Thyroid 2001;11:437–447.
25.
Dunn JT: Iodized oil in the treatment and prophylaxis of IDD; in Hetzel BS, Dunn JT, Stanbury JB (eds): The Prevention and Control of Iodine Deficiency Disorders. Amsterdam, Elsevier, 1987, pp 127–134.
26.
Gutekunst R, Benmiloud M, Karmarkar M, Pandav D, Pretell EA, Teichert HM: ICCIDD Iodized oil study group. J Endocrinol Invest 1992;15(suppl 2):122.
27.
Nordmeyer JP, Simons M, Wenzel C, Scholten T: How accurate is the assessment of thyroid volume by palpation? A prospective study of 316 patients. Exp Clin Endocrinol Diabetes 1997;105:366–371.
28.
Todd CH, Dunn JT: Intermittent oral administration of potassium iodide solution for the correction of iodine deficiency. Am J Clin Nutr 1998;67:1279–1283.
29.
Zimmermann MB, Hess SY, Molinari L, De Benoist B, Delange F, Braverman LE, et al: New reference values for thyroid volume by ultrasound in iodine-sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report. Am J Clin Nutr 2004;79:231–237.
30.
Jooste PL, Weight MJ, Lombard CJ: Short-term effectiveness of mandatory iodization of table salt, at an elevated iodine concentration, on the iodine and goiter status of schoolchildren with endemic goiter. Am J Clin Nutr 2000;71:75–80.
31.
Muros P, Ruiz-Lopez MD, Olea MF: Intake of iodine and major nutrients in an area of endemic goitre. J Nutr Sci Vitaminol (Tokyo) 1992;38:603–607.
32.
Dremier S, Coppee F, Delange F, Vassart G, Dumont JE, Van Sande J: Clinical review 84. Thyroid autonomy: mechanism and clinical effects. J Clin Endocrinol Metab 1996;81:4187–4193.
33.
Corvilain B, Contempre B, Longombe AO, Goyens P, Gervy-Decoster C, Lamy F, et al: Selenium and the thyroid: how the relationship was established. Am J Clin Nutr 1993;57(suppl 2):244S–248S.
34.
Florentino RF, Tanchoco CC, Rodriguez MP, Cruz AJ, Molano WL: Interactions among micronutrient deficiencies and undernutrition in the Philippines. Biomed Environ Sci 1996;9:348–357.
35.
Ingenbleek Y, De Visscher M: Hormonal and nutritional status: critical conditions for endemic goiter epidemiology? Metabolism 1979;28:9–19.
36.
Keyvani F, Yassai M, Kimiagar M: Vitamin A status and endemic goiter. Int J Vitam Nutr Res 1988;58:155–160.
37.
Untoro J, Ruz M, Gross R: Low environmental selenium availability as an additional determinant for goiter in East Java, Indonesia? Biol Trace Elem Res 1999;70:127–136.
38.
Wolde-Gebriel Z, Gebru H, Fisseha T, West CE: Severe vitamin A deficiency in a rural village in the Hararge region of Ethiopia. Eur J Clin Nutr 1993;47:104–114.
39.
Zimmermann MB, Wegmuller R, Zeder C, Chaouki N, Torresani T: The effects of vitamin A deficiency and vitamin A supplementation on thyroid function in goitrous children. J Clin Endocrinol Metab 2004;89:5441–5447.
40.
Beard J, Tobin B, Green W: Evidence for thyroid hormone deficiency in iron-deficient anemic rats. J Nutr 1989;119:772–778.
41.
Brigham D, Beard J: Iron and thermoregulation: a review. Crit Rev Food Sci Nutr 1996;36:747–763.
42.
Azizi F, Mirmiran P, Sheikholeslam R, Hedayati M, Rastmanesh R: The relation between serum ferritin and goiter, urinary iodine and thyroid hormone concentration. Int J Vitam Nutr Res 2002;72:296–299.
43.
Wolde-Gebriel Z, West CE, Gebru H, Tadesse AS, Fisseha T, Gabre P, et al: Interrelationship between vitamin A, iodine and iron status in schoolchildren in Shoa Region, central Ethiopia. Br J Nutr 1993;70:593–607.
44.
Yavuz O, Yavuz T, Kahraman C, Yesildal N, Bundak R: The relationship between iron status and thyroid hormones in adolescents living in an iodine deficient area. J Pediatr Endocrinol Metab 2004;17:1443–1449.
45.
Pathak P, Singh P, Kapil U, Raghuvanshi RS: Prevalence of iron, vitamin A, and iodine deficiencies amongst adolescent pregnant mothers. Indian J Pediatr 2003;70:299–301.
46.
Mesaros-Kanjski E, Kontosic I, Kusic Z, Kaic-Rak A, Dakovic N, Kuser J, et al: Endemic goitre and plasmatic levels of vitamins A and E in the school-children on the island of Krk, Croatia. Coll Antropol 1999;23:729–736.
47.
Zhang F, Liu N, Wang X, Zhu L, Chai Z: Study of trace elements in blood of thyroid disorder subjects before and after 131I therapy. Biol Trace Elem Res 2004;97:125–134.
48.
Zimmermann MB, Kohrle J: The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002;12:867–878.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.